Yale Trial

We believe that our patent pending technology can help people living with diabetes. That's why we have partnered with one of the most respected research universities in the world to gather the scientific data to prove it.
A clinical trial protocol to study the benefits of Circufiber™ socks has been approved by the Institutional Review Board at Yale University. We believe the data will prove scientifically that our Circulight IR™ technology improves local circulation in the lower leg and feet in diabetic patients. The trial was developed and will be conducted by Adam Mayerson, M.D., a leading endocrinologist and Associate Chief of Medicine at Yale New Haven Hospital. It is planned to begin in 2021 and will take approximately 6 months.